Database

Startups

Main Industry
Community and Lifestyle
Main Product/Service

Beauty Laser
Lightxel CO2 Laser
Lightxel CO2 Laser
Snowflake Diode Laser
Snowflake Diode Laser
PicoShine Picosecond Laser
PicoShine Picosecond Laser
Founded Year
2022
Unified Business No.
89157172
Status
Closed
Number of Employees
0
Total Paid-in Capital
5,000,000 (NT$)
Location of Company
Taiwan , Taipei City
Website
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
About the Company
Smedtrum integrates decades of R&D talents, actively conducts in-depth exchanges with the medical community, integrates theory and practice, and continuously improves to provide the most suitable products and services to our customers.



More ↓

Similar Companies

JUAN WOOD BUILDING MATERIALS CO., LTD.

One-stop service including design, construction, and operation maintenance of mini intelligent cell therapy product factories
A one-stop solution that covers the design, construction, operation, maintenance, and technical services for cell production in a miniature intelligent cell preparation plant meets customer needs for immune cells, stem cells, and exosomes.

The highly integrated modular design and exclusive efficient processes allow for economically beneficial cell production in small spaces, even within conventional hospital structures.

YJ Biotech is actively collaborating with medical institutions domestically and internationally to create a decentralized clinical cell manufacturing model. This approach aims to address end-to-end logistics challenges in cell product delivery, providing medical institutions' clients with an enhanced cellular therapy experience.